CMS vs CTMX · P/E 20, $22.42B cap vs rev $138.1M
CMS Energy Corporation (CMS) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the CMS and CTMX stock pages for the full models.
Not investment advice.